Skip header and navigation

8 records – page 1 of 1.

Cinacalcet (Sensipar) to treat secondary hyperparathyroidism in chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35371
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1465
Available Online
View Pamphlet
Secondary hyperparathyroidism is a condition that can be caused by kidney disease. It happens when your kidneys can’t filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medicine used to lower the level of parathyroid hormone in your blood. This will help to balance your calcium and phosphorous levels. Sensipar® is a brand name for cinacalcet. How to take this medicine and what side effects to watch for are reviewed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Cinacalcet
Renal Insufficiency, Chronic - drug therapy
Hyperparathyroidism, Secondary - drug therapy
Subjects (LCSH)
Chronic renal failure
Hyperparathyroidism
Kidneys--Diseases--Treatment
Abstract
Secondary hyperparathyroidism is a condition that can be caused by kidney disease. It happens when your kidneys can’t filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medicine used to lower the level of parathyroid hormone in your blood. This will help to balance your calcium and phosphorous levels. Sensipar® is a brand name for cinacalcet. How to take this medicine and what side effects to watch for are reviewed.
Notes
Previous title: Sensipar (Cinacalcet) to treat secondary hyperparathyroidism in chronic kidney disease
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
1465
Less detail

Lanthanum (Fosrenol) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35370
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1466
Available Online
View Pamphlet
Lanthanum (LAN-tha-num) is a medicine used to treat high levels of phosphorus (a mineral that builds strong bones and teeth) in the body. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. People with kidney disease are less able to remove phosphorus from the body. When phosphorus levels in the blood get too high, it pushes calcium out from your bones. This makes them weaker. Hemodialysis can remove some of the extra phosphorus, but medicin…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Lanthanum
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Lanthanum (LAN-tha-num) is a medicine used to treat high levels of phosphorus (a mineral that builds strong bones and teeth) in the body. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. People with kidney disease are less able to remove phosphorus from the body. When phosphorus levels in the blood get too high, it pushes calcium out from your bones. This makes them weaker. Hemodialysis can remove some of the extra phosphorus, but medicines such as lanthanam are often needed to help remove more. How to take the medicine and what side effects to watch for are reviewed. Fosrenol® is a brand name for lanthanum.
Notes
Previous title: Fosrenol (Lanthanum) and hemodialysis
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
1466
Less detail

One-Alpha® (alfacalcidol) and hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams36672
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1470
Available Online
View Pamphlet
One-Alpha® is a medicine that contains the active ingredient alfacalcidol, which is a form of vitamin D. The liver changes alfacalcidol to calcitriol, which is a form of vitamin D that can be used by the body. It acts as a hormone in your body to control the levels of calcium and phosphate, which are needed to build healthy bone. People with kidney disease cannot change enough vitamin D into calcitriol. We get vitamin D from sunlight, and from eating oily fish and milk products. This can cause …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
One-Alpha® is a medicine that contains the active ingredient alfacalcidol, which is a form of vitamin D. The liver changes alfacalcidol to calcitriol, which is a form of vitamin D that can be used by the body. It acts as a hormone in your body to control the levels of calcium and phosphate, which are needed to build healthy bone. People with kidney disease cannot change enough vitamin D into calcitriol. We get vitamin D from sunlight, and from eating oily fish and milk products. This can cause low levels of calcium in the blood and bone problems. This medicine skips the step done by the kidneys and increases the amount of vitamin D in your body that can be used. How to take the medicine and what side effects to watch for are reviewed. One-Alpha® is a brand name for alfacalcidol.
Responsibility
Prepared by: Renal Pharmacy Team, NSHA Renal Program
Pamphlet Number
1470
Less detail

Oral irons and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35375
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1469
Available Online
View Pamphlet
Your red blood cells need iron to help carry oxygen through your body. Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Oral irons, such as ferrous sulfate, ferrous gluconate, ferrous fumarate, and FeraMAX® 150, will give you enough iron to make make hemoglobin. This will make sure your body gets enough oxygen. How to take and store these medicines, and what side effects to watch for are reviewed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Oral irons and CKD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Renal Insufficiency, Chronic - drug therapy
Anemia, Iron-Deficiency - drug therapy
Subjects (LCSH)
Chronic renal failure--Complications
Iron deficiency anemia
Renal pharmacology
Abstract
Your red blood cells need iron to help carry oxygen through your body. Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Oral irons, such as ferrous sulfate, ferrous gluconate, ferrous fumarate, and FeraMAX® 150, will give you enough iron to make make hemoglobin. This will make sure your body gets enough oxygen. How to take and store these medicines, and what side effects to watch for are reviewed.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1469
Less detail

Over-the-counter medications & chronic kidney disease

https://libcat.nshealth.ca/en/permalink/chpams35643
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1636
Available Online
View Pamphlet
If you have chronic kidney disease, you need to be aware of certain over-the-counter medications that are your best choices and those that could cause unpleasant side effects. This pamphlet lists common ailments (e.g., cough and cold, fever or pain, allergies, upset stomach or heartburn, nausea or vomiting, diarrhea, constipation) and over-the-counter medications that are your best choices, their costs, and medications to stay away from. It also lists your best choices for multivitamins, creams…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([6] p.) : digital, PDF file
Subjects (MeSH)
Nonprescription Drugs
Renal Insufficiency, Chronic - drug therapy
Subjects (LCSH)
Drugs, Nonprescription
Chronic renal failure
Specialty
Medications
Abstract
If you have chronic kidney disease, you need to be aware of certain over-the-counter medications that are your best choices and those that could cause unpleasant side effects. This pamphlet lists common ailments (e.g., cough and cold, fever or pain, allergies, upset stomach or heartburn, nausea or vomiting, diarrhea, constipation) and over-the-counter medications that are your best choices, their costs, and medications to stay away from. It also lists your best choices for multivitamins, creams and ointments, and gives information on why herbal products are not recommended.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1636
Less detail

Rocaltrol® (calcitriol) and hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams36671
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1468
Available Online
View Pamphlet
Rocaltrol® is a medicine that contains the active ingredient calcitriol, which is a form of vitamin D that can be used by the body. It acts as a hormone in your body to control the levels of calcium and phosphate, which are needed to build healthy bone. People with kidney disease cannot change enough vitamin D into calcitriol. We get vitamin D from sunlight, and from eating oily fish and milk products. This can cause low levels of calcium in the blood and bone problems. This medicine skips the …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Calcitriol
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Rocaltrol® is a medicine that contains the active ingredient calcitriol, which is a form of vitamin D that can be used by the body. It acts as a hormone in your body to control the levels of calcium and phosphate, which are needed to build healthy bone. People with kidney disease cannot change enough vitamin D into calcitriol. We get vitamin D from sunlight, and from eating oily fish and milk products. This can cause low levels of calcium in the blood and bone problems. This medicine skips the step done by the kidneys and increases the amount of vitamin D in your body that can be used. How to take the medicine and what side effects to watch for are reviewed. Rocaltrol® is a brand name for calcitriol.
Responsibility
Prepared by: Renal Pharmacy Team, NSHA Renal Program
Pamphlet Number
1468
Less detail

Sevelamer (Renagel) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35372
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1464
Available Online
View Pamphlet
Sevelamer (se-VEL-a-mer) is a medicine used to treat high levels of phosphorus (a mineral that builds strong bones and teeth) in the body. People with kidney disease are less able to remove phosphorus from their body. When phosphorus levels in the blood get too high, it pushes calcium out from your bones. Hemodialysis can remove some of the extra phosphorus, but medicines such as sevelamer are often needed to help remove more. How to take sevelamer and what side effects to watch for are reviewe…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Sevelamer
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Chronic renal failure
Kidneys--Diseases--Treatment
Abstract
Sevelamer (se-VEL-a-mer) is a medicine used to treat high levels of phosphorus (a mineral that builds strong bones and teeth) in the body. People with kidney disease are less able to remove phosphorus from their body. When phosphorus levels in the blood get too high, it pushes calcium out from your bones. Hemodialysis can remove some of the extra phosphorus, but medicines such as sevelamer are often needed to help remove more. How to take sevelamer and what side effects to watch for are reviewed. Renagel® is a brand name for sevelamer.
Notes
Previous title: Renagel (Sevelamer) and Hemodialysis
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
1464
Less detail

Taking your medicines when you are sick: a guide for patients with chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams36519
Nova Scotia Health Authority. NSHA Renal Program. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1340
Available Online
View Pamphlet
This pamphlet lists medications to avoid when you are sick while managing chronic kidney disease. The pamphlet includes instructions for what to do if you are throwing up or have diarrhea, what to do if you are diabetic, as well as what to do if you are unsure whether to take a certain medication. It also gives a page for writing a sick day plan.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. NSHA Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - drug therapy
Renal Insufficiency, Chronic - drug therapy
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases
Abstract
This pamphlet lists medications to avoid when you are sick while managing chronic kidney disease. The pamphlet includes instructions for what to do if you are throwing up or have diarrhea, what to do if you are diabetic, as well as what to do if you are unsure whether to take a certain medication. It also gives a page for writing a sick day plan.
Notes
Previous title: Taking your Medicines when you are Ill - A Guide for Patients with Chronic Kidney Disease
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
1340
Less detail

8 records – page 1 of 1.